Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model

Area of Science:

• Epidemiology
• Health Economics
• Biostatistics

Background:

• Diabetes complications vary significantly by geographic region.
• Accurate modeling is crucial for evaluating global diabetes interventions.
• Existing models may not fully capture regional risk differences.

Purpose of the Study:

• To develop a practical model for diabetes progression accounting for regional risk variations.
• To improve model-based evaluations of diabetes interventions across diverse global populations.

Main Methods:

• A literature search identified clinical trials for model calibration.
• The Building, Relating, Assessing, and Validating Outcomes (BRAVO) model simulated diabetes complications.
• Regression methods estimated regional variations in myocardial infarction, congestive heart failure, stroke, angina, revascularization, and mortality.

Main Results:

• Significant regional variations were found in 4 of 6 outcomes.
• The United States showed higher risks for myocardial infarction and revascularization.
• Europe had a lower risk of stroke, and other regions had a lower risk of congestive heart failure.

Conclusions:

• Recalibrating the BRAVO model with regional data enhances prediction accuracy.
• The adjusted model is more reliable for multi-region populations in clinical trials.
• This approach supports more effective global diabetes management strategies.